Literature DB >> 7835597

Achalasia-associated squamous cell carcinoma of the esophagus: flow-cytometric and histological evaluation.

R Porschen1, G Molsberger, A Kühn, M Sarbia, F Borchard.   

Abstract

Although the risk of cancer is increased in patients with achalasia, biomarkers of an increased cancer risk have not been evaluated. In an esophagectomy specimen of a patient with achalasia-associated squamous cell carcinoma, normal mucosal and carcinomatous samples were systematically taken for flow cytometry and histology. The distribution of DNA aneuploidy and dysplasia was mapped within the resected specimen. Four of 10 tumor samples and 4 of 16 normal mucosal samples of the esophagus showed additional aneuploid stem lines. Gastric mucosa only showed diploid DNA histograms. S-phase fraction in normal esophageal samples (7.8% +/- 1.1%) was lower than in dysplastic and carcinomatous samples (8.8% +/- 2.4%; P = NS). Areas of mild to moderate dysplasia were detected in the esophageal mucosa adjacent to the neoplasm. This report shows the potential applicability of flow cytometry in the surveillance of patients with achalasia. However, prospective endoscopic studies with long follow-up periods are required before flow cytometric and histological parameters can be used as biomarkers of an increased cancer risk in achalasia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7835597     DOI: 10.1016/0016-5085(95)90084-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Achalasia--a disease of unknown cause that is often diagnosed too late.

Authors:  Ines Gockel; Michaela Müller; Johannes Schumacher
Journal:  Dtsch Arztebl Int       Date:  2012-03-23       Impact factor: 5.594

2.  Endoscopic approach to achalasia.

Authors:  Michaela Müller; Alexander J Eckardt; Till Wehrmann
Journal:  World J Gastrointest Endosc       Date:  2013-08-16

Review 3.  Management of primary achalasia: The role of endoscopy.

Authors:  Marisol Luján-Sanchis; Patricia Suárez-Callol; Ana Monzó-Gallego; Inmaculada Bort-Pérez; Lydia Plana-Campos; Luis Ferrer-Barceló; Laura Sanchis-Artero; María Llinares-Lloret; Juan Antonio Tuset-Ruiz; Javier Sempere-Garcia-Argüelles; Pilar Canelles-Gamir; Enrique Medina-Chuliá
Journal:  World J Gastrointest Endosc       Date:  2015-06-10

4.  Image cytometric DNA analysis of mucosal biopsies in patients with primary achalasia.

Authors:  I Gockel; P Kammerer; J Brieger; U-R Heinrich; W-J Mann; F Bittinger; V-F Eckardt; T Junginger
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

5.  Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma.

Authors:  D Boller; P Spieler; R Schoenegg; J Neuweiler; D Kradolfer; R Studer; R Grossenbacher; U Zuercher; C Meyenberger; J Borovicka
Journal:  Surg Endosc       Date:  2009-05-15       Impact factor: 4.584

6.  New endoscopic indicator of esophageal achalasia: "pinstripe pattern".

Authors:  Hitomi Minami; Hajime Isomoto; Satoshi Miuma; Yasutoshi Kobayashi; Naoyuki Yamaguchi; Shigetoshi Urabe; Kayoko Matsushima; Yuko Akazawa; Ken Ohnita; Fuminao Takeshima; Haruhiro Inoue; Kazuhiko Nakao
Journal:  PLoS One       Date:  2015-02-09       Impact factor: 3.240

7.  MicroRNA-130a is highly expressed in the esophageal mucosa of achalasia patients.

Authors:  Hiroyuki Shoji; Hajime Isomoto; Akira Yoshida; Haruo Ikeda; Hitomi Minami; Tsutomu Kanda; Shigetoshi Urabe; Kayoko Matsushima; Fuminao Takeshima; Kazuhiko Nakao; Haruhiro Inoue
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

8.  Improvement of endocytoscopic findings after per oral endoscopic myotomy (POEM) in esophageal achalasia; does POEM reduce the risk of developing esophageal carcinoma? Per oral endoscopic myotomy, endocytoscopy and carcinogenesis.

Authors:  Hitomi Minami; Naoyuki Yamaguchi; Kayoko Matsushima; Yuko Akazawa; Ken Ohnita; Fuminao Takeshima; Toshiyuki Nakayama; Tomayoshi Hayashi; Haruhiro Inoue; Kazuhiko Nakao; Hajime Isomoto
Journal:  BMC Gastroenterol       Date:  2013-01-30       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.